Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9H257: Variant p.Arg373Pro

Caspase recruitment domain-containing protein 9
Gene: CARD9
Feedback?
Variant information Variant position: help 373 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Arginine (R) to Proline (P) at position 373 (R373P, p.Arg373Pro). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and hydrophobic (P) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In IMD103; reduced cytokine production in response to C.albicans infection; does not affect NF-kappa-B transcriptional activity. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 373 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 536 The length of the canonical sequence.
Location on the sequence: help VAIERDQAIATREELHAQHA R GLQEKDALRKQVRELGEKAD The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         VAIERDQAIATREELHAQHARGLQEKDALRKQVRELGEKAD

Mouse                         VSIERDQAMASREELHAQCTQSFQDKDKLRKLVRELGEKAD

Rat                           VSIERDQAMTSREELHAQCAQSFQDKDKLRKQVRELDEKAD
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 536 Caspase recruitment domain-containing protein 9
Coiled coil 332 – 419
Alternative sequence 367 – 536 Missing. In isoform 3.



Literature citations
Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency.
Drewniak A.; Gazendam R.P.; Tool A.T.; van Houdt M.; Jansen M.H.; van Hamme J.L.; van Leeuwen E.M.; Roos D.; Scalais E.; de Beaufort C.; Janssen H.; van den Berg T.K.; Kuijpers T.W.;
Blood 121:2385-2392(2013)
Cited for: VARIANTS IMD103 SER-72 AND PRO-373; Inherited CARD9 deficiency in a child with invasive disease due to Exophiala dermatitidis and two older but asymptomatic siblings.
Imanaka Y.; Taniguchi M.; Doi T.; Tsumura M.; Nagaoka R.; Shimomura M.; Asano T.; Kagawa R.; Mizoguchi Y.; Karakawa S.; Arihiro K.; Imai K.; Morio T.; Casanova J.L.; Puel A.; Ohara O.; Kamei K.; Kobayashi M.; Okada S.;
J. Clin. Immunol. 41:975-986(2021)
Cited for: VARIANTS IMD103 GLU-196 AND PRO-373; CHARACTERIZATION OF VARIANTS IMD103 TRP-70; GLU-196 AND PRO-373; FUNCTION;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.